Table 2.
Logit Estimates of The Associates of a Rapid Trajectory of Price Increases in Generic Drugs. All Drugs
| Coefficient | Std Error | |
|---|---|---|
| Panel A | ||
| Baseline Payment | −1.414*** | (0.198) |
| Affected by Merger | −0.750 | (0.506) |
| Average HHI | 0.000256*** | (0.00001) |
| Average Doses per quarter | −0.0001 | (0.000) |
| Average share of branded in market | 0.925 | (0.763) |
| Panel B | ||
| Number of labelers (Reference: 0–4)) | ||
| 5–9 | −0.206 | ((0.290) |
| 10+ | −1.249** | (0.539) |
| Therapeutic Group (Reference: Miscellaneous) | ||
| Anti-Infective | 0.492 | (0.483) |
| Cancer | 0.683 | (0.922) |
| Cardiovascular | 0.795** | (0.373) |
| CNS | 0.467 | (0.318) |
| Hormones | −0.272 | (0.444) |
| Immunosuppressant | 2.256 | (1.389) |
| Maintenance Group (Reference: Both Primary and Acute) | ||
| Primarily Acute | 0.708** | (0.347) |
| Primarily Chronic | 0.474 | (0.431) |
| Constant | −2.036*** | (0.630) |
| Log Likelihood | − 307.161 | |
| Pseudo R2 | 0.255 | |
| Observations | 959 | |
Robust Standard Error in Parentheses, (***) p <0.01; (**) p <0.05; (*) p<0.10
We did not impute values for missing, though there were 9 missing values for the variable Pay